Impact of Introducing the Line Probe Assay on Time to Treatment Initiation of MDR-TB in Delhi, India

• Neeta Singla ,

  * E-mail: docneetasingla@gmail.com

  Affiliation National Institute of Tuberculosis & Respiratory Diseases, Delhi, India

  ⨯
• Srinath Satyanarayana,

  Affiliation International Union against Tuberculosis & Lung Disease, South-East Asia Regional Office, New Delhi, India

  ⨯
• Kuldeep Singh Sachdeva,

  Affiliation Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, New Delhi, India

  ⨯
• Rafael Van den Bergh,

  Affiliation Médecins Sans Frontières – Operational Centre Brussels, Operational Research Unit (LuxOR), Luxembourg

  ⨯
• Tony Reid,

  Affiliation Médecins Sans Frontières – Operational Centre Brussels, Operational Research Unit (LuxOR), Luxembourg

  ⨯
• Katherine Tayler-Smith,

  Affiliation Médecins Sans Frontières – Operational Centre Brussels, Operational Research Unit (LuxOR), Luxembourg

  ⨯
• V. P. Myneedu,

  Affiliation National Institute of Tuberculosis & Respiratory Diseases, Delhi, India

  ⨯
• Engy Ali,

  Affiliation Médecins Sans Frontières – Operational Centre Brussels, Operational Research Unit (LuxOR), Luxembourg

  ⨯
• Donald A. Enarson,

  Affiliation International Union against Tuberculosis & Lung Disease, Paris, France

  ⨯
• Digamber Behera,

  Affiliation Postgraduate Institute of Medical Education & Research, Chandigarh, India

  ⨯
• Rohit Sarin

  Affiliation National Institute of Tuberculosis & Respiratory Diseases, Delhi, India

  ⨯